{ "resourceType" : "AdministrableProductDefinition", "id" : "PhP-Trientinum-150mg-Filmcoatedtablet", "meta" : { "profile" : ["http://fhir.ch/ig/ch-epl/StructureDefinition/ch-idmp-administrableproductdefinition"] }, "text" : { "status" : "generated", "div" : "

Generated Narrative: AdministrableProductDefinition PhP-Trientinum-150mg-Filmcoatedtablet

Profile: AdministrableProductDefinition

status: Active

formOf: MedicinalProductDefinition: extension = Film-coated tablet; identifier = http://fhir.ch/ig/ch-epl/sid/mpid#Medical Product Identifier#CH-01100726-0677190010000; indication = Cuprior wird angewendet zur Behandlung von Morbus Wilson bei Erwachsenen, Jugendlichen und Kindern im Alter von 5 Jahren oder älter mit Unverträglichkeit gegenüber einer D-Penicillamin-Therapie.; legalStatusOfSupply = Medicinal product subject to medical or veterinary prescription (B); additionalMonitoringIndicator = No Warning; pediatricUseIndicator = Authorised for the treatment in children; classification = gilteritinib,NA KAS art. 12 para. 5 TPLO,Synthetic,Originator product,07. STOFFWECHSEL,07.99. Varia

administrableDoseForm: Film-coated tablet

unitOfPresentation: Tablet

RouteOfAdministrations

-Code
*Oral use
" }, "status" : "active", "formOf" : [{ "reference" : "MedicinalProductDefinition/Cuprior-150mg-Filmcoatedtablet" }], "administrableDoseForm" : { "coding" : [{ "system" : "http://standardterms.edqm.eu", "code" : "10221000", "display" : "Film-coated tablet" }] }, "unitOfPresentation" : { "coding" : [{ "system" : "http://standardterms.edqm.eu", "code" : "15054000", "display" : "Tablet" }] }, "routeOfAdministration" : [{ "code" : { "coding" : [{ "system" : "http://standardterms.edqm.eu", "code" : "20053000", "display" : "Oral use" }] } }] }